柔肝活血汤联合西药治疗乙型肝炎肝硬化合并门静脉高压临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R575

基金项目:


Clinical Study on Rougan Huoxue Tang Combined with Western Medicine for Hepatitis B Cirrhosis Complicated with Portal Hypertension
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察柔肝活血汤联合西药治疗乙型肝炎肝硬化合并门静脉高压的临床疗效。方法:选取96 例乙型肝炎肝硬化合并门静脉高压患者,按随机数字表法分为对照组和观察组各48 例。对照组给予恩替卡韦片、双环醇片及盐酸普萘洛尔片治疗,观察组在对照组基础上加用柔肝活血汤治疗,2 组均连续治疗8 周。比较2 组临床疗效,观察2 组肝功能、门静脉血流动力学及中医证候的改善情况。结果:观察组总有效率为91.67%,高于对照组的77.08%(P<0.05)。治疗后,2 组门静脉主干血流 速度(SPV) 均较治疗前升高,门静脉主干内径(DPV)、门静脉血流量(QPV) 均较治疗前降低(P<0.05);观察组SPV 高于对照组,DPV、QPV 均低于对照组(P<0.05)。治疗后,2 组丙氨酸转氨酶(ALT)、总胆红素(TBil) 水平均较治疗前降低(P<0.05),白蛋白(Alb) 水平均较治疗前升高(P<0.05);观察组ALT、TBil 水平均低于对照组(P<0.05),Alb 水平高于对照组(P<0.05)。治疗后,2 组Ⅳ型胶原(CⅣ)、透明质酸(HA)、Ⅲ型前胶原(PCⅢ)、层粘连蛋白(LN) 水平均较治疗前降低(P<0.05),观察组CⅣ、HA、PCⅢ、LN 水平均低于对照组(P<0.05)。治疗后,2 组中医证候积分均较治疗前降低(P<0.05),观察组中医证候积分低于对照组(P<0.05)。结论:柔肝活血汤联合西药治疗乙型肝炎肝硬化合并门静脉高压可提高临床疗效,有效改善患者的临床症状、肝功能及门静脉血流动力学。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Rougan Huoxue tang combined with western medicine for hepatitis B cirrhosis complicated with portal hypertension. Methods: A total of 96 cases of patients with hepatitis B cirrhosis complicated with portal hypertension were selected and divided into the control group and the observation group according to the random number table method, 48 cases in each group. The control group was treated with entecavir tablets, bicyclic alcohol tablets and propranolol hydrochloride tablets,and the observation group was additionally treated with Rougan Huoxue tang based on the treatment of the control group. Both groups were treated for eight weeks. The clinical effect in the two groups was compared,and the improvement of liver function,portal vein hemodynamics and Chinese medicine syndromes in the two groups were observed. Results:The total effective rate was 91.67% in the observation group,higher than that of 77.08% in the control group(P<0.05). After treatment, the portal vein blood flow velocity (SPV) in the two groups was increased when compared with that before treatment, and the main portal vein diameter (DPV) and the portal blood flow (QPV) were decreased (P<0.05);the SPV in the observation group was higher than that in the control group,and DPV and QPV in the observation group were lower than those in the control group(P<0.05). After treatment, the levels of alanine aminotransferase (ALT) and total bilirubin (TBil) in the two groups were decreased when compared with those before treatment (P<0.05), and the albumin (Alb) levels in the two groups were increased(P<0.05); the levels of ALT and TBil in the observation group were lower than those in the control group(P<0.05), and the Alb level was higher(P<0.05). After treatment, the levels of collagen Ⅳ (C Ⅳ), hyaluronic acid (HA), type Ⅲ procollagen (PC Ⅲ) and laminin (LN) in the two groups were decreased when compared with those before treatment(P<0.05),and the above levels in the observation group were lower than those in the control group(P<0.05). After treatment,Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment(P<0.05),and the score in the observation group was lower than that in the control group(P<0.05). Conclusion:The therapy of Rougan Huoxue tang combined with western medicine for hepatitis B cirrhosis complicated with portal hypertension can enhance the clinical effect,and effectively improve the clinical symptoms,liver function and portal vein hemodynamics patients.

    参考文献
    相似文献
    引证文献
引用本文

周依纯.柔肝活血汤联合西药治疗乙型肝炎肝硬化合并门静脉高压临床研究[J].新中医,2021,53(12):85-89

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-06-23
  • 出版日期:
文章二维码